This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on its inorganic growth story and an improving membership, Anthem (ANTM) holds enough potential to reap benefits for investors.
The Joint Corp. (JYNT) Is Up 9.86% in One Week: What You Should Know
by Zacks Equity Research
Does The Joint Corp. (JYNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
HCA Healthcare (HCA) Ties Up for Accelerating Digital Processes
by Zacks Equity Research
HCA Healthcare (HCA) forms alliance with Google Cloud with an aim to speed up digital transformation of the former, resulting in enhanced clinical and operational processes.
5 Solid Reasons Why The Joint (JYNT) Looks Attractive Now
by Zacks Equity Research
The Joint Corp. 's (JYNT) resilient business model along with its long-term expansion plans makes it a perfect fit for your investment portfolio.
Why Should You Hold Molina Healthcare (MOH) in Your Portfolio?
by Zacks Equity Research
Riding high on strategic measures and membership growth, Molina Healthcare (MOH) holds potential to reap benefits for investors.
The Joint Corp. (JYNT) Moves 17.8% Higher: Will This Strength Last?
by Zacks Equity Research
The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Anthem (ANTM), Epic Collaborate for Better Consumer Experience
by Zacks Equity Research
Anthem (ANTM) teams up with health information company Epic for bridging the gaps in medical care with near real-time data.
The Joint Corp. (JYNT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
The Joint Corp. (JYNT) delivered earnings and revenue surprises of 433.33% and 5.46%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate The Joint Corp. (JYNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
The Joint Corp. (JYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Joint Corp. (JYNT) Q4 Earnings Lag Estimates
by Zacks Equity Research
The Joint Corp. (JYNT) delivered earnings and revenue surprises of -20.00% and 2.42%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Centene's (CNC) Hawaii Arm to Keep Offering Healthcare Services
by Zacks Equity Research
Centene's (CNC) Hawaii subsidiary 'Ohana Health Plan is selected to continue catering services via the CSS plan.
Humana (HUM) Joins IBM Watson Health to Aid Member Experience
by Zacks Equity Research
Humana (HUM) teams up with IBM Watson Health to leverage the latter's conversational AI solution for providing better information to Humana Employer Group members.
3 Health Insurers That Crushed S&P YTD, Set to Rise Further
by Srijita Guha
We zero in on three health insurers that outperform the S&P Index YTD on the back of solid fundamentals. All these stocks hold prospects to continue the rally going forward.
Humana (HUM) Offers Medicare Advantage Health Plans for 2021
by Zacks Equity Research
Humana (HUM) unveils 2021 Medicare product offerings and better benefits in more counties across the nation.
Select Medical Enters Into Joint Venture With Rush University
by Zacks Equity Research
Select Medical (SEM) forms a joint venture with Rush University to manage healthcare operations at facilities in Chicago and Northwest Indiana area.
Humana's New Value-Based Care Plans to Better Healthcare
by Zacks Equity Research
Humana's (HUM) enriched value-based care programs are expected to curtail expenses as well as boost quality of healthcare.
Humana (HUM) Taps Salesforce for Better Healthcare Services
by Zacks Equity Research
Humana (HUM) teams up with Salesforce to provide improved healthcare services for its members.
Top Ranked Momentum Stocks to Buy for September 1st
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 1st.
Joint Corp's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Joint Corp.
Top Ranked Momentum Stocks to Buy for August 28th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 28th.
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
by Zacks Equity Research
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
Solid Near-Term HMO Industry Prospects on Multiple Tailwinds
by Sapna Bagaria
Health insurers are on a solid ground, given rising demand for Medicare policies, led by the increasing baby boomer population.
Here's Why You Should Add Humana (HUM) to Your Portfolio
by Zacks Equity Research
Riding high on its Medicare line of business and strategic initiatives, Humana (HUM) holds enough potential to reap benefits for investors.
Earnings Preview: The Joint Corp. (JYNT) Q2 Earnings Expected to Decline
by Zacks Equity Research
The Joint Corp. (JYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Best MedTech Stocks to Combat Coronavirus Crisis on Strong ROE
by Debanjana Dey
Here are some MedTech stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.